Search

Search Constraints

You searched for: Author/Creator Zucchetto, Antonella

Search Results

1. A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness. Issue 12 (December 2018)

2. ARHGDIA, a mutant TP53‐associated Rho GDP dissociation inhibitor, is over‐expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells. (14th February 2013)

3. Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study. Issue 5 (24th February 2021)

6. CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation‐dependent and ‐independent mechanisms. (17th October 2014)

7. Clinical significance of c.7544‐7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia. (20th November 2012)

8. Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy. (11th March 2022)

9. Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases. (28th January 2021)

10. COVID‐19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients. Issue 5 (30th August 2021)